TuHURA BIOSCIENCES, INC./NV Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
TuHURA BIOSCIENCES, INC./NV (HURA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 4.10 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.64M shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 2.47M shares, a 388.35% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 11.82M shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 12.33M shares, a 204.66% increase from fiscal 2024.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 4.05M shares.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 89.00K shares, a 14.10% increase from fiscal 2023.
- TuHURA BIOSCIENCES, INC./NV share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 78.00K shares, a 1.27% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 1.64M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 4.10M shares 10-Q · filed 2026-08-14 | 15.93M shares derived: sum of 3 quarters · filed 2026-08-14 | 15.93M shares derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | 2.47M shares 10-Q · filed 2026-05-15 | 14.29M shares derived: sum of 2 quarters · filed 2026-05-15 | 14.29M shares derived: sum of 3 quarters · filed 2026-05-15 | 14.29M shares derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | 11.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 11.82M shares derived: sum of 2 quarters · filed 2026-03-31 | 11.82M shares derived: sum of 3 quarters · filed 2026-03-31 | 12.33M shares 10-K · filed 2026-03-31 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 505.30K shares 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 505.30K shares 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | 505.30K shares 10-Q · filed 2025-05-15 | ||||
| 2024-12-31 | 4.05M shares 10-K · filed 2025-03-31 | ||||
| 2024-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | 0.00 shares derived: sum of 2 quarters · filed 2024-10-07 | 0.00 shares derived: sum of 3 quarters · filed 2024-10-07 | 89.00K shares 10-K · filed 2024-10-07 | |
| 2024-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-05-14 | 89.00K shares 10-Q · filed 2024-05-14 | 89.00K shares derived: sum of 4 quarters · filed 2024-10-07 | |
| 2023-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | 89.00K shares 10-Q · filed 2024-02-14 | 89.00K shares derived: sum of 3 quarters · filed 2024-10-07 | 97.00K shares derived: sum of 4 quarters · filed 2024-10-07 | |
| 2023-09-30 | 89.00K shares 10-Q · filed 2023-11-13 | 89.00K shares derived: sum of 2 quarters · filed 2024-10-07 | 97.00K shares derived: sum of 3 quarters · filed 2024-10-07 | -3.31M shares derived: sum of 4 quarters · filed 2024-10-07 | |
| 2023-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-07 | 8.00K shares derived: sum of 2 quarters · filed 2024-10-07 | -3.40M shares derived: sum of 3 quarters · filed 2024-10-07 | 78.00K shares 10-K · filed 2024-10-07 | |
| 2023-03-31 | 8.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | -3.40M shares derived: sum of 2 quarters · filed 2023-05-11 | 78.00K shares 10-Q · filed 2023-05-11 | -3.81M shares derived: sum of 4 quarters · filed 2023-09-18 | |
| 2022-12-31 | -3.41M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | 70.00K shares 10-Q · filed 2023-02-14 | -3.81M shares derived: sum of 3 quarters · filed 2023-09-18 | -3.81M shares derived: sum of 4 quarters · filed 2023-09-18 | |
| 2022-09-30 | 3.48M shares 10-Q · filed 2022-11-09 | -404.00K shares derived: sum of 2 quarters · filed 2023-09-18 | -394.00K shares derived: sum of 3 quarters · filed 2023-09-18 | 3.13M shares derived: sum of 4 quarters · filed 2023-09-18 | |
| 2022-06-30 | -3.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-18 | -3.88M shares derived: sum of 2 quarters · filed 2023-09-18 | -356.00K shares derived: sum of 3 quarters · filed 2023-09-18 | 79.00K shares 10-K · filed 2023-09-18 | 3.96K shares 10-K · filed 2022-09-27 |
| 2022-03-31 | 10.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | 3.53M shares derived: sum of 2 quarters · filed 2022-05-13 | 3.96M shares 10-Q · filed 2022-05-13 | -1.03M shares derived: sum of 4 quarters · filed 2022-09-27 | |
| 2021-12-31 | 3.52M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | 3.95M shares 10-Q · filed 2022-02-11 | -1.04M shares derived: sum of 3 quarters · filed 2022-09-27 | -1.04M shares derived: sum of 4 quarters · filed 2022-09-27 | |
| 2021-09-30 | 435.00K shares 10-Q · filed 2021-11-15 | -4.56M shares derived: sum of 2 quarters · filed 2022-09-27 | -4.56M shares derived: sum of 3 quarters · filed 2022-09-27 | -4.56M shares derived: sum of 4 quarters · filed 2022-09-27 | |
| 2021-06-30 | -4.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | -4.99M shares derived: sum of 2 quarters · filed 2022-09-27 | -4.99M shares derived: sum of 3 quarters · filed 2022-09-27 | 5.07K shares 10-K · filed 2022-09-27 | |
| 2021-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | 0.00 shares derived: sum of 2 quarters · filed 2021-05-13 | 5.00M shares 10-Q · filed 2021-05-13 | 4.51M shares derived: sum of 4 quarters · filed 2021-09-28 | |
| 2020-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12 | 5.00M shares 10-Q · filed 2021-02-12 | 4.51M shares derived: sum of 3 quarters · filed 2021-09-28 | 4.51M shares derived: sum of 4 quarters · filed 2021-09-28 | |
| 2020-09-30 | 5.00M shares 10-Q · filed 2020-11-12 | 4.51M shares derived: sum of 2 quarters · filed 2021-09-28 | 4.51M shares derived: sum of 3 quarters · filed 2021-09-28 | ||
| 2020-06-30 | -490.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | -490.53K shares derived: sum of 2 quarters · filed 2021-09-28 | 1.29K shares 10-K · filed 2021-09-28 | 1.29M shares 10-K · filed 2020-09-18 | |
| 2020-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | 491.82K shares 10-Q · filed 2020-05-13 | |||
| 2019-12-31 | 491.82K shares 10-Q · filed 2020-02-13 | ||||
| 2019-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | -270.00K shares derived: sum of 2 quarters · filed 2020-09-18 | 30.00K shares 10-K · filed 2020-09-18 | 152.70K shares 10-K · filed 2019-09-09 | |
| 2019-03-31 | -270.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | 30.00K shares 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | 300.00K shares 10-Q · filed 2019-02-11 | ||||
| 2018-06-30 | 30.00K shares 10-K · filed 2019-09-09 | 1.53M shares 10-K · filed 2018-09-24 | |||
| 2017-06-30 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-24 | 224.60K shares derived: sum of 2 quarters · filed 2018-09-24 | 264.60K shares 10-K · filed 2018-09-24 | ||
| 2017-03-31 | 224.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-12 | 264.60K shares 10-Q · filed 2017-05-12 | |||
| 2016-12-31 | 40.00K shares 10-Q · filed 2017-02-10 | ||||
| 2016-06-30 | -212.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | -647.50K shares derived: sum of 2 quarters · filed 2017-09-27 | -647.50K shares derived: sum of 3 quarters · filed 2017-09-27 | 177.50K shares 10-K · filed 2017-09-27 | |
| 2016-03-31 | -435.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-12 | -435.00K shares derived: sum of 2 quarters · filed 2016-05-12 | 390.00K shares 10-Q · filed 2016-05-12 | -285.00K shares derived: sum of 4 quarters · filed 2016-09-13 | |
| 2015-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-12 | 825.00K shares 10-Q · filed 2016-02-12 | 150.00K shares derived: sum of 3 quarters · filed 2016-09-13 | 150.00K shares derived: sum of 4 quarters · filed 2016-09-13 | |
| 2015-09-30 | 825.00K shares 10-Q · filed 2015-11-16 | 150.00K shares derived: sum of 2 quarters · filed 2016-09-13 | 150.00K shares derived: sum of 3 quarters · filed 2016-09-13 | 150.00K shares derived: sum of 4 quarters · filed 2016-09-13 | |
| 2015-06-30 | -675.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | -675.00K shares derived: sum of 2 quarters · filed 2016-09-13 | -675.00K shares derived: sum of 3 quarters · filed 2016-09-13 | 150.00K shares 10-K · filed 2016-09-13 | |
| 2015-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2015-05-15 | 825.00K shares 10-Q · filed 2015-05-15 | ||
| 2014-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-12 | 825.00K shares 10-Q · filed 2015-02-12 | |||
| 2014-09-30 | 825.00K shares 10-Q · filed 2014-11-07 | ||||
| 2014-03-31 | 900.00K shares 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | 900.00K shares 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |